Abstract Library

#1777 Tumour Size Is Not a Reliable Criterion for Resection of Patients with Non-Secreting Pancreatic Neuroendocrine Tumours: Results of an International, Multi-Centre, Operative Cohort

Introduction: Small pancreatic neuroendocrine tumours (pNETs) present a management dilemma between surveillance and resection.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Mills L, Drymousis P, Vashist Y, Burdelski C, Prachalias A,

Keywords: pNET, surveillance, incidental,

#1239 Histological Classification of Pancreatic Neuroendocrine Tumours: Optimising the Ki67 System

Introduction: Pancreatic neuroendocrine tumours are graded using the Ki67 antigen in accordance with the WHO 2010 classification. Despite the system’s widespread use, a wide variety of tumour behaviours have been described leading to various proposed revisions.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Mills L, Ramage J, Prachalias A, Srinivasan P, Menon K,

Keywords: G3,

#1233 CA 19-9: A Novel Role in the Prognosis of Pancreatic Neuroendocrine Tumors

Introduction: Prognostication is difficult for neuroendocrine tumours given their long survival. Staging, grading using Ki67 and receptor status are tools commonly used, but are not without their limitations. CA 19-9 is a tumour marker used in the diagnosis and follow-up of pancreatic adenocarcinomas despite multiple confounding factors, including jaundice. CA 19-9 is not useful in the diagnosis of PNETs having a sensitivity of only 19%, but it is not known whether it has other roles in PNETs.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Mills L, Ramage J, Quaglia A, Basuroy R, Srirajaskanthan R,

Keywords: CA 19-9,

#1209 Pancreatic Neuroendocrine Incidentalomas: When is Surgery in the Patient’s Best Interests?

Introduction: Small PNETs, many of which are diagnosed incidentally, pose a management dilemma. Whilst resection offers curative outcomes, the risks of surgery have led many to adopt surveillance strategies. 2cm is often used as a threshold for malignancy, but reports suggest that this value may not be valid.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Mills L, Ramage J, Prachalias A, Srinivasan P, Menon K,

Keywords: PNET,

#607 Goblet Cell Carcinoma of the Appendix: Acute v. Chronic Presentations

Introduction: Goblet Cell Carcinomas (GCC) are a rare neuroendocrine tumor (NET) of the appendix.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Basuroy R, Ngu A, Logan M, El-Mahallawi H, Cecil T,

Keywords: goblet cell carcinoma, presentations, appendix, mortality,